MG
IONS icon

Michael Gelband’s Ionis Pharmaceuticals IONS Stock Holding History

Michael Gelband’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Sell
35,645
-191,439
-84% -$14.4M 0.02% 685
2026
Q1 		$17.1M Buy
227,084
+143,209
+171% +$11.3M 0.14% 131
2025
Q4 		$6.64M Sell
83,875
-68,250
-45% -$5.14M 0.05% 375
2025
Q3 		$9.95M Buy
+152,125
New +$7.43M 0.1% 205
2025
Q2 		– Sell
-26,261
Closed -$792K – 1704
2025
Q1 		$792K Buy
+26,261
New +$860K 0.01% 984
2024
Q3 		– Sell
-209,194
Closed -$9.97M – 1829
2024
Q2 		$9.97M Sell
209,194
-6,699
-3% -$275K 0.07% 256
2024
Q1 		$9.36M Buy
215,893
+192,409
+819% +$9.17M 0.07% 219
2023
Q4 		$1.19M Buy
+23,484
New +$1.12M 0.01% 750
2023
Q2 		– Sell
-265,330
Closed -$9.48M – 2044
2023
Q1 		$9.48M Sell
265,330
-39,060
-13% -$1.47M 0.08% 294
2022
Q4 		$11.5M Buy
304,390
+297,973
+4,643% +$12.5M 0.17% 140
2022
Q3 		$284K Sell
6,417
-31,173
-83% -$1.31M ﹤0.01% 1538
2022
Q2 		$1.39M Buy
+37,590
New +$1.42M 0.02% 941
2022
Q1 		– Sell
-19,788
Closed -$602K – 2410
2021
Q4 		$602K Buy
19,788
+11,615
+142% +$366K 0.01% 1304
2021
Q3 		$274K Buy
+8,173
New +$308K ﹤0.01% 1653
2020
Q4 		– Sell
-26,507
Closed -$1.26M – 2151
2020
Q3 		$1.26M Buy
+26,507
New +$1.47M 0.03% 592
2020
Q2 		– Sell
-5,934
Closed -$281K – 1891
2020
Q1 		$281K Buy
5,934
+1,280
+28% +$71.3K 0.02% 672
2019
Q4 		$281K Buy
+4,654
New +$277K 0.01% 1173
2019
Q2 		– Sell
-63,522
Closed -$5.16M – 1216
2019
Q1 		$5.16M Buy
63,522
+58,022
+1,055% +$3.74M 0.38% 46
2018
Q4 		$297K Buy
+5,500
New +$281K 0.02% 198

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Michael Gelband's IONS Position: Q2 2026 in Review

Michael Gelband reduced its Ionis Pharmaceuticals (IONS) stake by 84% in Q2 2026, selling an estimated $14.4M and leaving 35,645 shares worth $2.83M. The position accounts for 0.02% of the portfolio, ranked #685.

Michael Gelband first reported a position in IONS in Q4 2018 and has held it in 19 quarters since. The position peaked at $17.1M in Q1 2026. 510 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Michael Gelband held 35,645 shares of Ionis Pharmaceuticals worth $2.83M as of Q2 2026.
  • Michael Gelband sold 191,439 Ionis Pharmaceuticals shares in Q2 2026, an estimated $14.4M.
  • Ionis Pharmaceuticals made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #685 holding.
  • Michael Gelband first reported a position in Ionis Pharmaceuticals in Q4 2018 and has held it in 19 quarters since.
  • Michael Gelband's Ionis Pharmaceuticals position peaked at $17.1M in Q1 2026.
  • 510 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.